Market Trends of Moist Wound Dressings Industry
Diabetic Ulcers Segment is Expected to Hold the Largest Share Over the Forecast Period
A diabetic foot ulcer is an open wound or sore that occurs in approximately 15.0% of patients with diabetes and is commonly located on the bottom of the foot, as per the NCBI research study. Foot ulcers are a common complication of diabetes that is not being managed through methods such as diet, exercise, and insulin treatment. Hydrocolloid and hydrogel dressings are the major moist wound dressings for diabetic foot ulcers.
The increasing cases of diabetes and prolonged diabetes leading to diabetic foot ulcers are the major drivers for the segment. For instance, according to the NCBI study published in September 2021, the annual incidence of diabetic foot ulceration was 2.2%, and the lifetime risk of foot ulceration among people with diabetes was up to 34%. Within a year, the recurrence rate of diabetic foot ulcers (DFU) can reach up to 40%. The same source also stated that 50-60% of foot ulcer patients survive five years after their initial presentation. Furthermore, according to the NCBI study published in August 2022, there were 9.1 to 26.1 million diabetic foot ulcers yearly. Approximately 15% to 25% of people with diabetes mellitus have experienced a diabetic foot ulcer at some point. The increasing cases of diabetes are also contributing to the increasing number of diabetic foot ulcer cases. For instance, according to the NCBI research study published in June 2021, the lifetime risk of developing a diabetic foot ulcer is between 19% and 34%, and up to one-third of the half a billion people with diabetes worldwide will develop a diabetic foot ulcer in their lifetime. The same source also reported that the annual incidence of foot ulceration is between 1.9% and 4.0% of the diabetic population. Thus, owing to increasing cases of diabetes and diabetic foot ulcers, considerable segment growth is anticipated over the forecast period.
North America is Expected to Witness Significant Share Over the Forecast Period
North America is expected to dominate the overall moist wound dressings market throughout the forecast period. The dominance is due to the rise in the prevalence of diabetes, burns, and surgeries, resulting in rising Surgical Site Infection (SSI) cases in the region. For instance, according to the CDC survey report published in January 2021, SSI is the most expensive healthcare-associated infection (HAI) type in the US, which accounted for an estimated annual cost of about USD 3.3 billion and affects more than 1.0 million additional inpatient days annually. The moist wound dressing is widely used in cases of surgical site infection. Thus, increasing cases of surgical site infection is expected to propel the demand for moist wound dressing, thereby surging the market growth in the region over the forecast period.
Key product launches, high concentration of market players or manufacturer's presence, and acquisition & partnerships among major players, and increasing cases of chronic diseases, burns, accidents, and chronic and acute wounds in the United States are some of the factors driving the growth of the moist wound dressings market in the country. For instance, much of the United States population is affected by chronic diseases, the most common cause of chronic wounds. For instance, a March 2021 article published in the Journal of Advances in Wound Care indicated that chronic wounds impact the quality of life (QoL) of nearly 2.5% of the United States population. Thus, owing to the country's increasing number of accident cases and chronic wounds, significant market growth is expected over the forecast period.
